Evidence map›Paper›PMID 40392529›Full record

SynthesisBJS open2025

Oncological, surgical, and cosmetic outcomes of endoscopic versus conventional nipple-sparing mastectomy: meta-analysis.

Ayla Carroll, Carlos Robles, Hung-Wen Lai, Lidia Blay, Piotr Pluta, Gauthier Rathat, Guillermo Peralta, Rami Younan, Giada Pozzi, Daniel Martinez Campo and 4 more

Abstract readMeta-AnalysisSystematic ReviewComparative Study
In one paragraph

Synthesis in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Three Strategic Pillars for Implementing Endoscopic Nipple-Sparing Mastectomy.JSLS : Journal of the Society of Laparoendoscopic Surgeons
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ayla CarrollApplied Medical, Rancho Santa Margarita, California, USA.ORCID 0000-0001-8068-9693
Carlos RoblesApplied Medical, Rancho Santa Margarita, California, USA.
Hung-Wen LaiComprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan.
Lidia BlayDepartment of General Surgery, Germans Trias University Hospital, Barcelona, Spain.
Piotr PlutaDepartment of Surgical Oncology and Breast Diseases, Polish Mother's Memorial Hospital-Research Institute in Lodz, Lodz, Poland.
Gauthier RathatHead of Breast Surgery Unit, University Hospital, Montpellier, France.
Guillermo PeraltaHead of the Breast Division, Cancer Center Tec 100, Director of BREAST Queretaro, Queretaro, Mexico.
Rami YounanDepartment of Surgery, Surgical Oncology Division, University of Montreal Health Center (CHUM), Montreal, Quebec, Canada.
Giada PozziDivision of Breast Surgical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, (To), Italy.
Daniel Martinez CampoDepartment of Obstetrics and Gynecology, Hospital Universitario de Torrejón, Madrid, Spain.
Robert MilliganDepartment of Breast Surgery, Queen Elizabeth Hospital, Gateshead, UK.
Glenn VergauwenDepartment of Gynecology, Ghent University Hospital, Ghent, Belgium.
Paolo CarcoforoChief of Breast Surgery Unit, University-Hospital of Ferrara, Cona, Ferrara, Italy.
Antonio ToescaDivision of Breast Surgical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, (To), Italy.

Funding

Applied Medical
6 · The paper itself

Abstract

backgroundEndoscopic nipple-sparing mastectomy has been developed to improve the cosmetic outcomes of conventional nipple-sparing mastectomy. This meta-analysis compares surgical, quality of life and oncological outcomes of endoscopic nipple-sparing mastectomy versus conventional nipple-sparing mastectomy.

methodsPubMed and Embase were systematically reviewed to identify literature relevant to endoscopic nipple-sparing mastectomy and conventional nipple-sparing mastectomy literature published through to August 2023. The risk of bias was assessed using the Newcastle-Ottawa Scale, and proportional and pairwise random-effects meta-analysis was performed. Surgical (operative time, duration of hospital stay, blood loss, necrosis, overall complications), quality of life (cosmesis, pain, nipple-areolar complex sensitivity) and oncological outcomes (margin positivity, recurrence, metastasis and breast cancer-specific mortality rate) were evaluated.

resultsOf 1286 articles retrieved, 51 endoscopic nipple-sparing mastectomy studies and 12 conventional nipple-sparing mastectomy reviews were analysed; 10 non-randomized comparative studies (656 patients) were included in the pairwise analysis and 36 studies (comparative and single-group cohort studies; 2612 patients) in the proportional meta-analysis. Results showed no differences in oncological outcomes (mean follow-up of up to 52 months), comparable overall (OR = 0.49; P = 0.100) and necrotic complications (OR = 0.45; P = 0.150), and improved cosmetic satisfaction (OR = 1.88; P = 0.020). Comparing only single-incision endoscopic nipple-sparing mastectomy to conventional nipple-sparing mastectomy significantly reduced postoperative necrosis (OR = 0.19; P = 0.008). The proportional meta-analysis produced oncological and surgical outcome rates comparable to or lower than conventional nipple-sparing mastectomy rates. However, longer operative time (weighted mean difference = 43.08 min; P < 0.00001) and duration of hospital stay (weighted mean difference = 0.72 days; P = 0.0007) were observed.

conclusionEndoscopic nipple-sparing mastectomy does not affect oncological outcomes in up to 52 months mean follow-up when compared with conventional nipple-sparing mastectomy and provides better cosmetic satisfaction, with a reduced risk of necrosis after single-incision endoscopic nipple-sparing mastectomy. As such, endoscopic nipple-sparing mastectomy may become a viable breast surgery option.

Indexed as

Breast NeoplasmsEndoscopyMastectomy, SubcutaneousNipplesEstheticsFemaleHumansLength of StayMastectomyOperative TimeOrgan Sparing TreatmentsPostoperative ComplicationsQuality of LifeTreatment Outcome

Identifiers

PMID40392529
PMCPMC12090896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.